cber blood establishment registration and product listing jan o’brien blood registration...
TRANSCRIPT
CC BBEE RR
Blood Establishment Registration and Product Listing
Jan O’BrienBlood Registration Coordinator
DBA, OBRR, CBER September 15, 2009
2 CC BBEE RR
Outline • What are Establishment Registration and Product
Listing?• Definitions• Why must I register and list with FDA?• Who must register and list with FDA? • How do I register and list with FDA?• What will I be required to do? • Are there any exemptions to registration and/or
listing?• What is the difference between “registration and
listing” and getting a license?
3 CC BBEE RR
What are Establishment Registration and Product Listing?• What is Establishment Registration?
− Notification to FDA by an establishment operator of his name, places of business, and all such establishments.
− Section 510(a)(b)− Routinely referred to as “Registration”
• What is product listing?− Filing with the Secretary a list of all drugs …. which are
being manufactured, prepared, propagated, compounded, or processed by him for commercial distribution
− Section 510(j)(1)− Routinely referred to as “Listing”
4 CC BBEE RR
Registration• Required under the FD&C Act
• Described in 21 CFR 607.7
• All owners or operators of establishments that engage in the manufacture of blood products must register and submit a list of every blood product in commercial distribution with FDA (21 CFR 607.20)
• Does not permit shipping of blood product in interstate commerce− May engage in intrastate shipment
5 CC BBEE RR
Establishments• Defined in 21 CFR 607.3(c)
• A place of business under one management at one general physical location
• Includes blood and plasma centers, blood banks, transfusion services, other blood product manufacturers and independent laboratories that engage in quality control and testing for registered blood establishments
6 CC BBEE RR
Manufacture• Defined in 21 CFR 607.3(d)
• Collection, preparation, processing, compatibility testing and other procedures of any blood product that meets the definition of a drug
• Includes testing, control procedures, labeling and repackaging of the blood products
• Manufacturing steps can be performed by entity that owns product or by a contractor
7 CC BBEE RR
Blood Product• Defined in 21 CFR 607.3(b)
• A drug which consists of human whole blood, plasma or serum or any product derived from human whole blood, plasma or serum
• Includes those products that meet the definition of a device under the FD&C Act that are licensed under the PHS Act
8 CC BBEE RR
Manufacturer• Defined in 21 CFR 600.3(t)
• Legal person or entity engaged in the manufacture of products subject to licensure
• Manufacturer (licensed or unlicensed) assumes responsibility for compliance with applicable product and establishment standards, even if manufacturing is performed by contractor
9 CC BBEE RR
Who Must Register & List?21 CFR 607.20
• Facilities− Collection facility
− Community blood bank
− Component preparation facility
− Hospital blood bank
− Plasmapheresis center
− Product testing laboratory
− Distribution center
• Brokers − who take possession and
manipulate and/or relabel product
10 CC BBEE RR
How Do I Register & List ?
• Submit registration form to CBER within 5 days after beginning manufacturing operations (21 CFR 607.21 & 607.22)
• FDA Form 2830: Blood Establishment Registration and Product Listing
11 CC BBEE RR
How Do I Register & List? (cont.)
• Complete a form for each facility and list all products in commercial distribution.
− Include both licensed and unlicensed products
• Electronic registration (eBER)−Electronic registration may be required in the
future
−http://www.fda.gov/BiologicsBloodVaccines/GuidanceComplianceRegulatoryInformation/EstablishmentRegistration/BloodEstablishmentRegistration/default.htm
12 CC BBEE RR
US Food and Drug Administration Home Page
13 CC BBEE RR
Blood & Blood Products page
14 CC BBEE RR
Blood & Blood Products page (continued)
15 CC BBEE RR
Blood Establishment Registration and Product Listing page
16 CC BBEE RR
Blood Establishment Registration and Product Listing page
(continued)
17 CC BBEE RR
CBER On-Line – Login Screen
18 CC BBEE RR
CBER On-Line – Main Menu
19 CC BBEE RR
Blood Establishment Registration – Select
Establishment
20 CC BBEE RR
Blood Establishment Registration – Registration
Profile
21 CC BBEE RR
Blood Establishment Registration and Product
listing
22 CC BBEE RR
Responsibilities of Registration & Listing
• Each manufacturer must register Annually between November 15 and December 31 and must update their blood product listing information every June and December. Send updates to FDA through eBER (21 CFR 607.21)
• Manufacturer is responsible for complying with FDA regulations and cGMPs (including labeling, BPD, and fatality reporting)
• Facility will be inspected by FDA every 2 years
23 CC BBEE RR
Exemption From Registration & Listing
• Described in 21 CFR 607.65
• Any facility that does not manufacture products
• Any transfusion service that:− Only performs compatibility testing and transfusion
− Does not routinely collect or process products
− Only prepares recovered plasma for further manufacture or RBCs for transfusion from Whole Blood
− Pool platelets or cryoprecipitate immediately before transfusion
24 CC BBEE RR
Exemption From Registration & Listing (cont)
− Aliquots or divides components into smaller containers for ease of transfusion
− Thaws frozen plasma or cryoprecipitate to prepare for transfusion
− Are certified under the Clinical Laboratory Improvement Amendments (CLIA) of 1988 or has met equivalent requirements as determined by the Centers for Medicare and Medicaid Services (CMS)
• Brokers who do not take possession or do not manipulate or re-label product
25 CC BBEE RR
What Is The Difference Between “Registration & Listing” and Getting A
License?• All blood establishments that manufacture blood
products or perform a manufacturing step must register & list
• Those manufacturers that intend to routinely distribute the blood products across state lines (interstate commerce) must also hold an approved FDA license− Submit application for license and documents for review
− Undergo FDA pre-license inspection
− Approvals are specific for product and facility
− FDA license number on label of approved products
26 CC BBEE RR
Registered Blood Establishments That Are Not Licensed
• 10-15% of transfused blood is prepared in unlicensed, registered blood banks
• CBER does not review product manufacturing submissions from facilities that are not licensed unless they:− Request a “alternative procedure” (21 CFR 640.120)
− Apply for licensure (21 CFR 601.2)
27 CC BBEE RR
Helpful Website Addresses
•General CBER information http://www.fda.gov/BiologicsBloodVaccines/default.htm/
•Guidance Documentshttp://www.fda.gov/BiologicsBloodVaccines/Guidance
ComplianceRegulatoryInformation/default.htm
•Forms (356h, 2830, 2567)http://
www.fda.gov/AboutFDA/ReportsManualsForms/Forms/default.htm
28 CC BBEE RR
General Contact Information• Mailing Address
Director, Division of Blood Applications, OBRR, CBER, FDAHFM-370c/o Document Control Center, HFM-991401 Rockville Pike, Suite 200NRockville, MD 20852-1448
• Telephone – (301) 827-3543• Fax – (301) 827-3534 • Blood and Plasma Branch Consumer Safety
Officers
29 CC BBEE RR
Blood Registration & Listing Contact Info Jan O’Brien
Blood Registration Coordinator
Telephone 301-827-3546
E-Mail address: [email protected]